Form 8-K - Current report:
SEC Accession No. 0001193125-25-044103
Filing Date
2025-03-03
Accepted
2025-03-03 16:05:28
Documents
14
Period of Report
2025-02-25
Items
Item 3.03: Material Modifications to Rights of Security Holders
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d38831d8k.htm   iXBRL 8-K 37280
2 EX-3.1 d38831dex31.htm EX-3.1 232686
  Complete submission text file 0001193125-25-044103.txt   440039

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA bmrn-20250225.xsd EX-101.SCH 2852
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE bmrn-20250225_lab.xml EX-101.LAB 17979
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE bmrn-20250225_pre.xml EX-101.PRE 11259
17 EXTRACTED XBRL INSTANCE DOCUMENT d38831d8k_htm.xml XML 3783
Mailing Address 105 DIGITAL DRIVE NOVATO CA 94949
Business Address 105 DIGITAL DRIVE NOVATO CA 94949 4155066700
BIOMARIN PHARMACEUTICAL INC (Filer) CIK: 0001048477 (see all company filings)

EIN.: 680397820 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-26727 | Film No.: 25697773
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)